RedTram News Search Engine
Русский  English Українська  Français  Polski  Deutsch  Italiano  Español  中文   
14 July 2008 year (time zone GMT 00:00)  Number of sources in English: 4955
Navigating the themes
Navigating the regions
All Themes Health & Beauty Pharmaceutics World
Pharmaceutics (World) RSS 2.0

Focus on Energy Efficiency

14.07.2008 17:10    pharmaceutical-technology.com
A Boehringer Ingelheim global team set itself the goal of systematically identifying and communicating examples of best practices in energy efficiency within the company. Energy efficiency is also to be given higher priority during the evaluation of new investments. Another
World    Pharmaceutics    Press-releases


Boehringer Ingelheim to Acquire Actimis Pharmaceuticals

14.07.2008 17:10    pharmaceutical-technology.com
Boehringer Ingelheim GmbH announced an agreement to acquire Actimis Pharmaceuticals, Inc., a privately owned biotech company based in San Diego. The acquisition will occur through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the
World    Pharmaceutics    Press-releases

Affymetrix Inc, Manufacturing Facility

14.07.2008 11:24    pharmaceutical-technology.com
Affymetrix Inc was one of the pioneering companies in genetic microarray technology in the 1980s. It now manufactures products for genetic research including diagnostic tools and microarray systems for genome elucidation. DNA microarrays are high-throughput technology used for research in
World    Pharmaceutics    Press-releases

Hyetts Express Deliveries

14.07.2008 11:22    drugdevelopment-technology.com
Hyetts' fleet enable temperature critical medical and healthcare products to be delivered safely, at the right time and at the correct temperature throughout the UK and across Europe.Hyetts' Express Delivery fleet provide temperature controlled vehicles specialising in:Multi-temperature deliveriesTemperature-critical pharmaceutical deliveriesSame
World    Pharmaceutics    Press-releases


Semagacestat - Gamma Secretase Inhibitor for Alzheimer's Disease (AD)

14.07.2008 11:22    drugdevelopment-technology.com
Semagacestat (LY-450139) is a gamma secretase inhibitor under development by Eli Lilly as a treatment for Alzheimer's disease (AD). Now in advanced-stage development, it is hoped that this new anti-dementia drug will help delay the onset of severe AD and
World    Pharmaceutics    Press-releases

1